Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: A new weapon to blunt prostate cancer growth

Cell Cycle

Volumn 7, Issue 21, 2008, Pages 3320-3326

  Hafeez, Bilal Bin ^a   Asim, Mohammad ^a   Siddiqui, Imtiaz Ahmad ^a   Adhami, Vaqar Mustafa ^a   Murtaza, Imtiyaz ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Delphinidin; NF B; Prostate cancer

Indexed keywords

ANDROGEN; BENZYLOXYCARBONYL VALYLALANYLASPARTIC ACID FLUOROMETHYLKETONE; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; DELPHINIDIN; DNA; I KAPPA B ALPHA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P50; SERINE; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; IC 50; PROSTATE CANCER; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 55849108797     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.21.6969     Document Type: Review

References (43)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96.
2. Syed DN, Khan N, Afaq F, Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 2007; 16:2193-203.
3. Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 2005; 9:1193-5.
4. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 2008; 10:475-510.
5. Bell DR, Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. J Appl Physiol 2006; 100:1164-70.
6. Vuorela S, Kreander K, Karonen M, Nieminen R, Hämäläinen M, Galkin A, et al. Preclinical evaluation of rapeseeds, raspberry and pine bark phenolics for health related effects. J Agric Food Chem 2005; 53:5922-31.
7. Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappaB in normal human epidermal keratinocytes. Photochem Photobiol 2005; 81:38-45.
8. Mazza G. Anthocyanins in grapes and grape products. Crit Rev Food Sci Nutr 1995; 35:341-71.
9. Hou DX, Fujii M, Terahara N, Yoshimoto M. Molecular mechanisms behind the chemopreventive effects of anthocyanidins. J Biomed Biotechnol 2004; 2004:321-5.
10. Noda Y, Kaneyuki T, Mori A, Packer L. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin and pelargonidin. J Agric Food Chem 2002; 50:166-71.
11. Hou DX, Yanagita T, Uto T, Masuzaki S, Fujii M. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochem Pharmacol 2005; 70:417-25.
12. Azevedo L, Alves de Lima PL, Gomes JC, Stringheta PC, Ribeiro DA, Salvadori DM. Differential response related to genotoxicity between eggplant (Solanum melanogena) skin aqueous extract and its main purified anthocyanin (delphinidin) in vivo. Food Chem Toxicol 2007; 45:852-8.
13. Lamy S, Blanchette M, Michaud-Levesque J, Lafleur R, Durocher Y, Moghrabi A, et al. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis 2006; 27:989-96.
14. Afaq F, Zaman N, Khan N, Syed DN, Zaid MA, Mukhtar H. Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin present in pigmented fruits and vegetables. Int J Cancer 2008; 123:1508-15.
15. Lamy S, Beaulieu E, Labbé D, Bédard V, Moghrabi A, Barrette S, et al. Delphinidin, a dietary anthocyanidin, inhibits platelet derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 2008; 29:1033-41.
16. Syed DN, Afaq F, Sarfaraz S, Khan N, Kedlaya R, Setaluri V, et al. Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation. Toxicol Appl Pharmacol 2008; (PMID:18499206).
17. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 2005; 102:14813-8.
18. Malik A, Mukhtar H. Prostate cancer prevention through pomegranate fruit. Cell Cycle 2006; 4:371-3.
19. Hafeez BB, Siddiqui IA, AsimM, Malik A, Afaq F, Adhami VM, et al. A Dietary Anthocyanidin Delphinidin Induces Apoptosis of Human Prostate Cancer PC3 Cells in vitro and in vivo: Involvement of NFκB signaling. (Cancer Res, in press).
20. Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14:3-15.
21. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000; 33:261-74.
22. Ross JS, Jennings TA, Nazeer T, Sheehan CE, Fisher HA, Kauffman RA, et al. Prognostic factors in prostate cancer. Am J Clin Pathol 2003; 120:85-100.
23. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997; 100:2952-60.
24. Zhou M, Gu L, Zhu N, Woods WG, Findley HW. Transfection of a dominant-negative mutant NFκB inhibitor (IκBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IκBm and p53. Oncogene 2003; 22:8137-44.
25. Afaq F, Saleem M, Krueger CG, Reed JD, Mukhtar H. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NFkappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 2005; 113:423-33.
26. Nicholson DW. Caspase structure, proteolytic substrates and function during apoptotic cell death. Cell Death Differ 1999; 6:1028-42.
27. Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharmacol Ther 2001; 92:57-70.
28. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75:241-51.
29. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7:541-6.
30. Revelos K, Petraki C, Gregorakis A, Scorilas A, Papanastasiou P, Koutsilieris M. Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy. Anticancer Res 2005; 25:3123-33.
31. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266:1821-8.
32. Vermeulen K, Berneman ZN, Van Bockstaele DR. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36:165-75.
33. McDonald ER, El-Deiry WS. Cell cycle control as a basis for cancer drug development. Int J Oncol 2000; 16:871-86.
34. 1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 2000; 8:1487-503.
35. 2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer 2008; 98:523-8.
36. 2/M phase transition. Cold Spring Harb Symp Quant Biol 1991; 56:503-13.
37. van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993; 262:2050-4.
38. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNFalpha-induced apoptosis by NFkappaB. Science 1996; 274:787-9.
39. Karin M, Greten FR. NFkappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5:749-59.
40. Karin M. Nuclear factor kappaB in cancer development and progression. Nature 2006; 441:431-6.
41. Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 2004; 10:8460-4.
42. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF[kappa]B activity. Annu Rev Immunol 2000; 18:621-63.
43. Saleem M, Afaq F, Adhami VM, Mukhtar H. Lupeol modulates NFκB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004; 23:5203-14.